Document is current

Any future updates will be listed below

Levels of interleukin-1 beta can predict response to tocilizumab therapy in rheumatoid arthritis: the PETITE (predictors of effectiveness of tocilizumab therapy) study

Crossref DOI link: https://doi.org/10.1007/s00296-015-3379-x

Published Online: 2015-10-05

Published Print: 2016-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark